| scholarly article | Q13442814 |
| P50 | author | Pascal Lutumba | Q28817154 |
| Marleen Boelaert | Q28817180 | ||
| Victor Kande | Q29056952 | ||
| P2093 | author name string | David Hendrickx | |
| Patrick Mitashi | |||
| Alain Mpanya | |||
| Oscar Luboya | |||
| Albert Kanyinda | |||
| Crispin Lumbala | |||
| Mimy Vuna | |||
| Pierre Lefèvre | |||
| Valéry Tshilombo | |||
| P2860 | cites work | Trypanosoma brucei gambiense African trypanosomiasis: differences between men and women in severity of disease and response to treatment. | Q54126588 |
| Human African trypanosomiasis (sleeping sickness): epidemiological update | Q58845365 | ||
| NECT is next: implementing the new drug combination therapy for Trypanosoma brucei gambiense sleeping sickness | Q28474074 | ||
| Re-emergence of epidemic sleeping sickness in southern Sudan | Q34248743 | ||
| The Atlas of human African trypanosomiasis: a contribution to global mapping of neglected tropical diseases | Q34335313 | ||
| Trypanosomiasis control, Democratic Republic of Congo, 1993-2003 | Q35847379 | ||
| Trypanosomiasis relapse after melarsoprol therapy, Democratic Republic of Congo, 1982-2001. | Q36009318 | ||
| Control of human African trypanosomiasis in Luba in equatorial Guinea:evaluation of three methods | Q36669085 | ||
| Human African trypanosomiasis: pharmacological re-engagement with a neglected disease. | Q36740553 | ||
| High failure rates of melarsoprol for sleeping sickness, Democratic Republic of Congo | Q37009244 | ||
| Trypanosomiasis from Trypanosoma brucei gambiense in the center of north-west Uganda. Evaluation of 5 years of control (1987-1991) | Q38889126 | ||
| Clinical description of encephalopathic syndromes and risk factors for their occurrence and outcome during melarsoprol treatment of human African trypanosomiasis | Q38912273 | ||
| Drug toxicity and cost as barriers to community participation in HAT control in the Democratic Republic of Congo | Q39401306 | ||
| The effectiveness of active population screening and treatment for sleeping sickness control in the Democratic Republic of Congo | Q39401311 | ||
| Resurgence of sleeping sickness in Tambura County, Sudan. | Q46771888 | ||
| Hot-cold food and medical theories: overview and introduction | Q47402313 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Democratic Republic of the Congo | Q974 |
| African trypanosomiasis | Q203133 | ||
| infectious disease | Q18123741 | ||
| P304 | page(s) | e1467 | |
| P577 | publication date | 2012-01-01 | |
| P1433 | published in | PLoS Neglected Tropical Diseases | Q3359737 |
| P1476 | title | Should I get screened for sleeping sickness? A qualitative study in Kasai province, Democratic Republic of Congo | |
| P478 | volume | 6 |
| Q55333958 | Assessing Strategies Against Gambiense Sleeping Sickness Through Mathematical Modeling. |
| Q46255516 | Barcoding in trypanosomes. |
| Q47139318 | Comparative genomics identifies male accessory gland proteins in five Glossina species |
| Q58707255 | Cost-effectiveness of using a rapid diagnostic test to screen for human African trypanosomiasis in the Democratic Republic of the Congo |
| Q34395455 | Diagnostic work-up of neurological syndromes in a rural African setting: knowledge, attitudes and practices of health care providers |
| Q27026504 | Epidemiology of human African trypanosomiasis |
| Q58842233 | Ethical Considerations for Global Health Decision-Making: Justice-Enhanced Cost-Effectiveness Analysis of New Technologies for |
| Q99707476 | Feasibility of community-based control of tsetse: A pilot project using Tiny Targets in the Democratic Republic of Congo |
| Q31132495 | Forecasting Human African Trypanosomiasis Prevalences from Population Screening Data Using Continuous Time Models. |
| Q35345427 | From health advice to taboo: community perspectives on the treatment of sleeping sickness in the Democratic Republic of Congo, a qualitative study |
| Q92616533 | Gambian human African trypanosomiasis in North West Uganda. Are we on course for the 2020 target? |
| Q34339853 | Global aspirations, local realities: the role of social science research in controlling neglected tropical diseases |
| Q58842320 | Human African trypanosomiasis |
| Q27317424 | Implications of Heterogeneous Biting Exposure and Animal Hosts on Trypanosomiasis brucei gambiense Transmission and Control |
| Q64245502 | Is the elimination of 'sleeping sickness' affordable? Who will pay the price? Assessing the financial burden for the elimination of human African trypanosomiasis in sub-Saharan Africa |
| Q57061698 | Knowledge, attitudes and practices about human African trypanosomiasis and their implications in designing intervention strategies for Yei county, South Sudan |
| Q37609404 | Mapping the capacities of fixed health facilities to cover people at risk of gambiense human African trypanosomiasis |
| Q38916889 | Measuring and modelling the effects of systematic non-adherence to mass drug administration |
| Q56556804 | NTD control and health system strengthening |
| Q92264389 | New WHO guidelines for treatment of gambiense human African trypanosomiasis including fexinidazole: substantial changes for clinical practice |
| Q28555206 | Predicting the Impact of Intervention Strategies for Sleeping Sickness in Two High-Endemicity Health Zones of the Democratic Republic of Congo |
| Q34613645 | Proteomic selection of immunodiagnostic antigens for human African trypanosomiasis and generation of a prototype lateral flow immunodiagnostic device |
| Q36202328 | Quantitative evaluation of the strategy to eliminate human African trypanosomiasis in the Democratic Republic of Congo. |
| Q36153041 | The Role of Folate Transport in Antifolate Drug Action in Trypanosoma brucei |
| Q47186581 | The socio-economic burden of human African trypanosomiasis and the coping strategies of households in the South Western Kenya foci |
Search more.